Study of Efficacy and Safety of AVTR101 in Sarcopenic Elderly

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2025
The goal of this clinical trial is to primarily evaluate the efficacy of AVTR101 to placebo on physical performance in sarcopenia patients. Participants will: Take AVTR101 or a placebo three times daily for 12 weeks Visit the clinic once every 4 weeks for checkups and tests
Epistemonikos ID: 49fd240a474b33f01b9187702595f1fa5b70f281
First added on: Mar 27, 2025